Migraine Clinical Trials in Pittsburgh, PA

We are looking for adolescents who experience migraines to take part in a clinical trial. No health insurance is required. The study medicine and any trial-related procedures will be provided.

Researchers are investigating the efficacy and safety of an investigational medication in preventing migraines in children and teenagers. Participants in the study will be randomly assigned to receive either the investigational medication or a placebo. The insights from this study aim to contribute to advancements in migraine treatments and offer valuable knowledge in managing migraine episodes in younger populations. There is an optional open-label, extension phase following the double-blind, treatment phase. Choosing to participate in a study is a significant decision. It's crucial to have all the information you need. If the study catches your interest, the research site will be ready to help. They'll provide details about the study, answer any questions, and discuss potential risks, benefits, and possible compensation.

This phase 2/3 study aims to assess the safety and effectiveness of an investigational drug (SEP-363856) as an additional treatment for adults with Major Depressive Disorder and who have not had success with antidepressants in treating their depression symptoms. This study may be suitable for you if you have been diagnosed with depression and your previous antidepressant treatments have not been effective. Should you express interest, the research site will contact you directly to provide further details and address any questions you may have about study requirements, risks/benefits, and compensation.

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

This study aims to evaluate the safety, immune response, and tolerability of an investigational vaccine designed to protect against both COVID-19 and seasonal influenza in adults aged 18 to 64 years. Participants will be randomly assigned to receive the investigational vaccine or a currently available vaccine. The study involves a single vaccination followed by monitoring over several months. Should you express interest, the research site will contact you directly to provide further details and address any questions you may have about study requirements, risks/benefits, and compensation.

The main objectives of this study are to assess the safety and effectiveness of an investigational vaccine aimed at preventing norovirus, commonly known as the stomach flu. Participants will be randomly assigned to receive either the investigational vaccine or a placebo. Should you express interest, you will be contacted directly by the research site, which will provide further details and answer any questions you may have about study requirements, risks/benefits, and any compensation.